UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Similar documents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. REVOLUTION LIGHTING TECHNOLOGIES (Name of Issuer)

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Main Street Capital Corp.

ShotSpotter, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Taubman Centers, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934*

Inventergy Global, Inc (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Algodon Wines & Luxury Development Group, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Signet Jewelers (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Spark Therapeutics, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

Realogy Holdings Corp.

BARRETT BUSINESS SERVICES, INC. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number)

Floor & Décor Holdings, Inc. (Name of Issuer)

Silvercrest Asset Management Group Inc. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Rosehill Resources Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Limbach Holdings, Inc (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G T100 (CUSIP Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Ecology & Environment, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:

OAKTREE CAPITAL GROUP, LLC Filed by JMB CAPITAL PARTNERS MASTER FUND L.P.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

Recro Pharma, Inc. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

Alliqua BioMedical, Inc.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Amendment No. 3. Under the Securities Exchange Act of 1934

KAYNE ANDERSON MIDSTREAM ENERGY FUND, INC. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

KINGSTONE COMPANIES, INC.

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

Limbach Holdings, Inc. (Name of Issuer)

Common Stock, par value $0.01 per share (Title of Class of Securities)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. KLR Energy Acquisition Corp.

united StateS SeCuritieS and exchange COMMiSSiOn Washington, D.C SCHeDuLe 13g

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Rule 13d-102)

ACCESS INTEGRATED TECHNOLOGIES INC

LEGACY RESERVES LP Filed by BROTHERS PRODUCTION COMPANY, INC.

SECURITIES AND EXCHANGE COMMISSION Washington, DC SCHEDULE 13G (Rule 13d-102)

Propetro Holding Corp. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment 2)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

American Midstream Partners, LP (Name of Issuer)

<SEQUENCE>1 <FILENAME>cpst_sc13g.txt. SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G

PURE BIOSCIENCE, INC. Filed by OKUNO DALE

Everi Holdings Inc. (Name of Issuer)

USANA HEALTH SCIENCES, INC. (Name of Issuer)

Videocon d2h Limited (Name of Issuer)

Canada Goose Holdings Inc. (Name of Issuer)

American Midstream Partners, LP (Name of Issuer)

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

LEGACY RESERVES LP Filed by MORIAH PROPERTIES, LTD.

Vascular Biogenics Ltd.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

UNITED THERAPEUTICS CORP Filed by SHUMWAY CAPITAL PARTNERS LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

LEAR CORP Filed by MERRILL LYNCH PIERCE FENNER & SMITH INC

ECO-STIM ENERGY SOLUTIONS, INC. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Amendment No. ) Under the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934.

EATON CORP PLC Filed by WELLINGTON MANAGEMENT CO LLP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C

BRIDGEPOINT EDUCATION, INC. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC

us92927k1025_ txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G Under the Securities Exchange Act of 1934

SCHEDULE 13G* (Rule 13d-102) Corbus Pharmaceuticals Holdings, Inc. (Name of Issuer)

NELNET INC Filed by CEDAR HILL CAPITAL PARTNERS, LLC

Securities and Exchange Commission. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

3M CO Filed by BLACKROCK INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

MarineMax Inc. (Name of Issuer)

FISERV INC Filed by BLACKROCK INC.

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934.

SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934

THERAVANCE INC Filed by BAUPOST GROUP LLC/MA

Techne Corp (Name of Issuer)

Transcription:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) TAUBMAN CENTERS INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 876664103 (CUSIP Number) CALENDAR YEAR 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, seethe Notes).

1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY): APG Asset Management US Inc. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [X] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America 5 SOLE VOTING POWER 0 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 6 SHARED VOTING POWER 2,675,000 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 2,675,000 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,675,000 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.41%* 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO * Based on 60,712,665 shares of common stock outstanding as of 11/1/2017, as reported on the Issuer's Report on 10-Q for the period ended September 30, 2017 filed with the Securities and Exchange Commission on 11/2/2017. 2

1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY): APG Asset Management, N.V. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [X] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Kingdom of the Netherlands 5 SOLE VOTING POWER 0 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 6 SHARED VOTING POWER 2,675,000 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 2,675,000 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,675,000 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.41%* 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO * Based on 60,712,665 shares of common stock outstanding as of 11/1/2017, as reported on the Issuer's Report on 10-Q for the period ended September 30, 2017 filed with the Securities and Exchange Commission on 11/2/2017. 3

1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY): APG Groep, N.V. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [X] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Kingdom of the Netherlands 5 SOLE VOTING POWER 0 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 6 SHARED VOTING POWER 2,675,000 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 2,675,000 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,675,000 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.41%* 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO * Based on 60,712,665 shares of common stock outstanding as of 11/1/2017, as reported on the Issuer's Report on 10-Q for the period ended September 30, 2017 filed with the Securities and Exchange Commission on 11/2/2017. 4

1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY): Stichting Pensioenfonds ABP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [X] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Kingdom of the Netherlands 5 SOLE VOTING POWER 0 NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 6 SHARED VOTING POWER 2,675,000 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 2,675,000 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,675,000 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.41%* 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) FI * Based on 60,712,665 shares of common stock outstanding as of 11/1/2017, as reported on the Issuer's Report on 10-Q for the period ended September 30, 2017 filed with the Securities and Exchange Commission on 11/2/2017. 5

ITEM 1(a) - NAME OF ISSUER: Taubman Centers Inc. ITEM 1(b) - ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 200 E Long Lake Rd Suite 300 Bloomfield Hills, MI 48304-2324 ITEM 2(a) - NAME OF PERSON FILING: (1) APG Asset Management US Inc. (2) APG Asset Management, N.V. (3) APG Groep, N.V. (4) Stichting Pensioenfonds ABP ITEM 2(b) - ADDRESS OF PRINCIPAL BUSINESS OFFICE: (1) 666 3 rd Ave., 2 nd Floor, New York, NY 10017 (2) Gustav Mahlerplein 3, 1082 MS Amsterdam (3) Oude Lindestraat 70, Postbus 6401, Heerlen, Netherlands (4) PO Box 4806, 6401 JL Heerlen, Netherlands ITEM 2(c) - CITIZENSHIP: (1) United States of America (2) Kingdom of the Netherlands (3) Kingdom of the Netherlands (4) Kingdom of the Netherlands ITEM 2(d) - TITLE OF CLASS OF SECURITIES: Common Stock ITEM 2(e) - CUSIP NUMBER: 876664103 6

ITEM 3 - If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: NOT APPLICABLE. (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a- 8); (e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-u.s. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-u.s. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: 7

ITEM 4 - OWNERSHIP: The information herein is incorporated by reference to the cover page of this Schedule 13G. APG Asset Management, N.V. ("APG NL") is wholly-owned by APG Groep, N.V. ("APG Groep") and is the investment manager with respect to the securities to which this statement relates. Pursuant to an Investment Management Agreement, APG NL has delegated its investment and voting power with respect to such securities to APG Asset Management US, Inc. ("APG US"), which is its whollyowned subsidiary. Stichting Pensioenfonds ABP is the majority owner of APG Groep. By virtue of the relationships described above, each of the reporting persons may be deemed to share beneficial ownership of the securities to which this statement relates and may be deemed to be a member of a "group" (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended). However, each reporting person disclaims membership in any such group. ITEM 5 - OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: If this statement is being filed to report the fact that as of the date hereof the reporting persons have ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ X ] 1 ITEM 6 - OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not applicable. ITEM 7 - IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY: Not applicable. ITEM 8 - IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not applicable. ITEM 9 - NOTICE OF DISSOLUTION OF GROUP: Not applicable. ITEM 10 - CERTIFICATION: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. 1 If you are filing an exit filing please put insert "[X]". 8

SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 31, 2018 APG ASSET MANAGEMENT US, INC. /s/ APG ASSET MANAGEMENT, N.V. /s/ APG GROEP, N.V. /s/ STICHTING PENSIOENFONDS ABP /s/ 9

JOINT FILING AGREEMENT EXHIBIT 1 The undersigned hereby agree that the statement on Schedule 13G to which this Agreement is annexed as Exhibit 1, and any amendments thereto, is and will be filed on behalf of each of them in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Date: January 31, 2018 APG ASSET MANAGEMENT US, INC. /s/ APG ASSET MANAGEMENT, N.V. /s/ APG GROEP, N.V. /s/ STICHTING PENSIOENFONDS ABP /s/ 10